Armata Pharmaceuticals, Inc. (ARMP) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Vaxart, Inc.

Sonnet BioTherapeutics Holdings, Inc.

Sangamo Therapeutics, Inc.

Armata Pharmaceuticals, Inc.

Century Therapeutics, Inc.

Greenwich LifeSciences, Inc.

Aadi Bioscience, Inc.

Theseus Pharmaceuticals, Inc.

Galectin Therapeutics, Inc.

PepGen Inc.

Omega Therapeutics, Inc.

Why is Armata Pharmaceuticals, Inc. ?

Unrated Stock - No Analysis Available

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

No Data Found

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

38.41%

EBIT Growth (5y)

-11.14%

EBIT to Interest (avg)

-20.19

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

-1.78

Sales to Capital Employed (avg)

0.09

Tax Ratio

Dividend Payout Ratio

Pledged Shares

Institutional Holding

10.74%

ROCE (avg)

ROE (avg)

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

-1.40

EV to EBIT

-17.92

EV to EBITDA

-18.84

EV to Capital Employed

16.36

EV to Sales

114.07

PEG Ratio

Dividend Yield

ROCE (Latest)

-91.29%

ROE (Latest)

Negative BV

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bullish

RSI

No Signal

Bollinger Bands

Bullish

Moving Averages

Bullish (Daily)

KST

Mildly Bearish

Bullish

Dow Theory

Mildly Bullish

OBV

Mildly Bullish

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

8What is working for the Company

OPERATING CASH FLOW(Y)

Highest at USD -23.96 MM

NET PROFIT(HY)

Higher at USD -27.4 MM

RAW MATERIAL COST(Y)

Fallen by -84.88% (YoY

DEBTORS TURNOVER RATIO(HY)

Highest at 36.51 times

-18What is not working for the Company

NET SALES(9M)

At USD 3.03 MM has Grown at -35.45%

CASH AND EQV(HY)

Lowest at USD 13.44 MM

DEBT-EQUITY RATIO (HY)

Highest at -118.4 %

INTEREST(Q)

Highest at USD 5.56 MM

OPERATING PROFIT(Q)

Lowest at USD -8.33 MM

PRE-TAX PROFIT(Q)

Lowest at USD -14.28 MM

NET PROFIT(Q)

Lowest at USD -14.28 MM

Here's what is working for Armata Pharmaceuticals, Inc.

Operating Cash Flow

Highest at USD -23.96 MM and Grown

In each year in the last three years

MOJO Watch

The company has generated higher cash revenues from business operations

Operating Cash Flows (USD MM)

Debtors Turnover Ratio

Highest at 36.51 times

in the last five Semi-Annual periods

MOJO Watch

Company has been able to sell its Debtors faster

Debtors Turnover Ratio

Raw Material Cost

Fallen by -84.88% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Armata Pharmaceuticals, Inc.

Net Sales

At USD 3.03 MM has Grown at -35.45%

Year on Year (YoY)

MOJO Watch

Near term sales trend is very negative

Net Sales (USD MM)

Interest

At USD 5.56 MM has Grown at 15%

period on period (QoQ)

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (USD MM)

Interest

Highest at USD 5.56 MM

in the last five periods and Increased by 15% (QoQ)

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (USD MM)

Operating Profit

Lowest at USD -8.33 MM

in the last five periods

MOJO Watch

Near term Operating Profit trend is negative

Operating Profit (USD MM)

Pre-Tax Profit

Lowest at USD -14.28 MM

in the last five periods

MOJO Watch

Near term Pre-Tax Profit trend is negative

Pre-Tax Profit (USD MM)

Pre-Tax Profit

At USD -14.28 MM has Fallen at -20.48%

over average net sales of the previous four periods of USD -11.86 MM

MOJO Watch

Near term Pre-Tax Profit trend is negative

Pre-Tax Profit (USD MM)

Net Profit

Lowest at USD -14.28 MM

in the last five periods

MOJO Watch

Near term Net Profit trend is negative

Net Profit (USD MM)

Net Profit

At USD -14.28 MM has Fallen at -20.48%

over average net sales of the previous four periods of USD -11.86 MM

MOJO Watch

Near term Net Profit trend is negative

Net Profit (USD MM)

Cash and Eqv

Lowest at USD 13.44 MM

in the last six Semi-Annual periods

MOJO Watch

Short Term liquidity is deteriorating

Cash and Cash Equivalents

Debt-Equity Ratio

Highest at -118.4 %

in the last five Semi-Annual periods

MOJO Watch

The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio